Prionics Acquires CEDI Diagnostics
Strategic Partnership With Life Science Innovation Centre
Prionics announced the acquisition of CEDI-Diagnostics. The Dutch firm is part of the Wageningen University and Research Centre (Wageningen UR). Through the purchase of CEDI, Prionics will acquire a substantial number of new products and gain rights to commercialise developments made by the research centre. Prionics and Wageningen UR have additionally agreed on a strategic partnership for the development of future innovations in farm animal diagnostics.
"We have acquired a firm with tests proven on the market and we gain access to future developments of a unique global research centre," says Dr Markus Moser, co-CEO of Prionics.
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
See the theme worlds for related content
Last viewed contents
MagForce Selected as Winner of 2010 STEP Award in the Category Product/Technology - Prize awarded in recognition of company's innovation and growth potential
List_of_subjects_in_Gray's_Anatomy:_XI._Splanchnology
MagForce AG Announces Changes to Supervisory and Management Boards
Adipose-Derived Stem & Regenerative Cells Improve Fat Graft Retention in Preclinical Study

No chance for environment-relieving plastic decomposition by bacteria - Burst Hope
